Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
3.66M
-
Shares change
-
+85.7K
-
Total reported value, excl. options
-
$15.8M
-
Value change
-
+$370K
-
Put/Call ratio
-
0.97
-
Number of buys
-
12
-
Number of sells
-
-15
-
Price
-
$4.30
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q1 2023
53 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q1 2023.
Anixa Biosciences Inc - Common Stock (ANIX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.66M shares
of 37.9M outstanding shares and own 9.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.34M shares), UBS Group AG (639K shares), GEODE CAPITAL MANAGEMENT, LLC (274K shares), BlackRock Inc. (247K shares), Long Focus Capital Management, LLC (166K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (156K shares), STATE STREET CORP (102K shares), Bank of New York Mellon Corp (97.6K shares), JANE STREET GROUP, LLC (61.8K shares), and NORTHERN TRUST CORP (58.5K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.